Eledon Share Price

Eledon Share Price

NASDAQ: ELDN | Micro Cap | Healthcare
$2.03
+$0.04 (2.27%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Eledon Stock Performance

Open
$2.05
Prev. Close
$1.99
Circuit Range
N/A
Day Range
$1.96 - $2.09
Year Range
$1.37 - $4.49
Volume
73,815
Average Traded
$2.04

Eledon Share Price Today

As of 19 November 2026, Eledon Pharmaceuticals, Inc.'s share price is $2.03. The stock opened at $2.05, compared to its previous close of $1.99. During today's trading session, Eledon Pharmaceuticals, Inc.'s share price traded between $1.96 and $2.09, with an average price of $2.02. Over the past 52 weeks, the stock has recorded a high of $4.49 and a low of $1.37. In terms of performance, Eledon Pharmaceuticals, Inc.'s share price has declined by 46.86% over the last six months and is up 24.54% on a year-on-year basis.

Eledon Share Price Chart

Line chart of the Eledon price trend over the selected period. The price rose overall, ranging from 1.99 to 2.09, ending at 2.03.
$1.96$2.09
L
Show Current Price
H

Eledon Stock Fundamentals & Key Indicators

Market Cap
$166.13M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.00
Revenue (TTM)
$0.00
Return On Equity (TTM)
-273.05%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
71.13%

Eledon Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$13.13-$36.94-$30.24-$3.79
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-181.34%18.14%87.47%

Eledon Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$87.97-$116.54-$36.18-$45.62
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-32.48%68.95%-26.09%

Eledon Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets33.3233.6832.9433.28
Current Assets135.69143.7356.1359.52
Total Assets169.01177.4189.0792.79
Non Current Liabilities13.8947.6977.962.14
Current Liabilities18.3411.583.96.48
Total Liabilities32.2359.2781.868.61
Shareholders' Equity81.0962.45-48.4984.18

Eledon Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-62.34-47.27-39.53-28.42
Investing10.79-70.31-45.290.0
Financing53.81133.5233.020.0

Corporate Actions

Split
Ex-date: 05 Oct 2020

About Eledon

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Eledon Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.83
$2.04
-26.57%
Oct 2026
$2.50
$2.79
+10.08%
Sep 2026
$2.94
$2.53
-23.80%
Aug 2026
$3.48
$3.32
-1.48%
Jul 2026
$4.00
$3.37
-14.25%
Jun 2026
$3.72
$3.93
+2.88%
May 2026
$3.62
$3.82
+5.23%
Apr 2026
$3.10
$3.63
+17.86%
Mar 2026
$2.57
$3.08
+17.78%
Feb 2026
$2.17
$2.62
+19.41%
Jan 2026
$1.52
$2.19
+45.51%
Dec 2025
$1.60
$1.50
-7.67%

Eledon Share Price FAQs